Standish Fleming

This profile gathers the share dealings of Standish Fleming across 2 companies, led by Acorda Therapeutics Inc and Ambit Biosciences Corp. Between 15 February 2006 and 21 May 2013, the trades on record add up to 12 filings.

No open-market sale appears; the market trades are 3 purchases worth €2.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2013: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €582k.

Most recently, on 21 May 2013, the filings show a transaction in Ambit Biosciences Corp. The most recent open-market purchase was published on 21 May 2013, 4,920 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.